Market Place
Sourcing Support
Triastek`s T22 Receives FDA Clearance of IND Application
31 Jan 2024 //
GLOBENEWSWIRE
Triastek Completes USD 20.4 Million Pre-C Funding Round
28 Sep 2023 //
GLOBENEWSWIRE
Triastek Reports Positive FIH Results from Study of T21
21 Jul 2023 //
GLOBENEWSWIRE
Triastek Reports Positive FIH Results from Study of T21
20 Jul 2023 //
GLOBENEWSWIRE
Triastek Honored with Healthcare Application Award at the TCT Awards Ceremony
08 Jun 2023 //
GLOBENEWSWIRE
Triastek Receives FDA IND Clearance for 3D Printed Medicine
21 Nov 2022 //
PRNEWSWIRE
Lilly taps Triastek to use 3D printing for targeted gut delivery
18 Jul 2022 //
FIERCEPHARMA
Triastek, Lilly collaborate to explore application of 3D printing technology
13 Jul 2022 //
PRNEWSWIRE
Triastek and Siemens Enter Pharma 4.0 Collaboration
22 Mar 2022 //
CONTRACTPHARMA
Triastek, Siemens collaborate to accelerate digital transformation
17 Mar 2022 //
PRNEWSWIRE
Triastek closes $ 50 million financing
26 Jun 2021 //
PR NEWSWIRE
Triastek completes its series B financing with a value of USD 50 million
26 Jun 2021 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.